Asia Pacific Flow Cytometry Market
Tamanho do mercado em biliões de dólares
CAGR :
% 
 Período de previsão |
2023 –2030 |
 Tamanho do mercado (ano base ) | USD 1,068.66 Million |
 Tamanho do mercado ( Ano de previsão) | USD 2,395.04 Million |
 CAGR |
% |
| Principais participantes do mercado |
|
>Mercado de Citometria de Fluxo Ásia-Pacífico, por produto (instrumentos de citometria de fluxo, reagentes e consumíveis, software, acessórios e serviços), tecnologia (citometria de fluxo baseada em células e citometria de fluxo baseada em grânulos), aplicação (aplicações de investigação, aplicações clínicas e Aplicações Industriais), Utilizador Final (Institutos Académicos e de Investigação, Hospitais, Empresas Farmacêuticas e de Biotecnologia, Laboratórios de Ensaios Clínicos, Banco de Sangue e Outros), Canal de Distribuição (Concursos Directos e Vendas a Retalho) - Tendências e Previsão do Sector para 2030.
Análise e insights do mercado de citometria de fluxo da Ásia-Pacífico
Asia-Pacific flow cytometry market is driven by the factors such as the increasing prevalence of chronic diseases, growing demand for new technologies in the flow cytometry market, which enhances its demand, as well as increasing investment in research and development, which leads to market crescimento. Atualmente, os gastos em saúde têm aumentado nos países desenvolvidos e emergentes, o que deverá criar uma vantagem competitiva para os fabricantes desenvolverem novos e inovadores mercados de citometria de fluxo. No entanto, prevê-se que o elevado custo dos instrumentos de citometria de fluxo restrinja o crescimento do mercado de citometria de fluxo da Ásia-Pacífico.
O relatório de mercado de citometria de fluxo da Ásia-Pacífico fornece detalhes de quota de mercado, novos desenvolvimentos e análise de pipeline de produtos, o impacto dos participantes do mercado doméstico e localizado, analisa as oportunidades em termos de bolsas de receitas emergentes, mudanças nas regulamentações de mercado, aprovações de produtos, decisões estratégicas, lançamentos de produtos, expansões geográficas e inovações tecnológicas no mercado. Para compreender a análise e o cenário do mercado, contacte-nos para um resumo do analista. A nossa equipa irá ajudá-lo a criar uma solução de impacto na receita para atingir a meta desejada. A escalabilidade e expansão do negócio das unidades de retalho nos países em desenvolvimento de diversas regiões e a parceria com fornecedores para a distribuição segura de máquinas e medicamentos são os principais impulsionadores que impulsionaram a procura do mercado no período de previsão.
Espera-se que o mercado de citometria de fluxo da Ásia-Pacífico ganhe crescimento de mercado no período de previsão de 2023 a 2030. A Data Bridge Market Research analisa que o mercado está a crescer com um CAGR de 10,7% no período de previsão de 2023 a 2030 e prevê-se que atinja 2.395,04 milhões de dólares até 2030, contra 1.068,66 milhões de dólares em 2022.
|
Métrica de reporte |
Detalhes |
|
Período de previsão |
2023 a 2030 |
|
Ano base |
2022 |
|
Anos históricos |
2021 (personalizável para 2015-2020) |
|
Unidades Quantitativas |
Receita em milhões de dólares |
|
Segmentos cobertos |
By Product (Flow Cytometry Instruments, Reagents and Consumables, Software, Accessories, and Services), Technology (Cell-Based Flow Cytometry and Bead-Based Flow Cytometry), Application (Research Applications, Clinical Applications, and Industrial Applications), End User (Academic & Research Institutes, Hospitals, Pharmaceutical & Biotechnology Companies, Clinical Testing Laboratories, Blood Bank, and Others), Distribution Channel (Direct Tenders, and Retail Sales) |
|
Countries Covered |
Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, and the rest of the Asia-Pacific |
|
Market Players Covered |
Thermo Fisher Scientific Inc. (U.S.), BD(U.S.), Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Sysmex Corporation (Japan), Coherent Corp. (U.S.), Beckman Coulter, Inc. (A subsidiary of Danaher Corporation) (U.S.), Cytek Biosciences(U.S.), BIOMÉRIEUX (France), Q2 Solutions (a Subsidiary of IQVIA) (U.S.), Cytonome/ST, LLC (U.S.), Merck KGaA (Germany), Sony Biotechnology Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), Enzo Biochem Inc. (U.S.), Takara Bio Inc. (Japan), CellKraft Biotech Pvt. Ltd. (India), IKEDA SCIENTIFIC Co., Ltd.(Japan), Apogee Flow Systems Ltd. (U.K.), Sartorius AG (Germany), Bay bioscience Co., Ltd.(Japan), Elabscience Biotechnology Inc. (U.S.), Miltenyi Biotec (Germany), CytoBuoy b.v.(Europe), ORFLO Technologies(U.S.), BioLegend, Inc. (U.S.), NeoGenomics Laboratories(U.S.), Nexcelom Bioscience LLC(U.S.), among others |
Market Definition
Flow cytometry is a key process for screening cells from a heterologous cell mixture used in cell sorting, counting, protein regeneration, and engineering. The analysis of cell surface and intracellular molecule expression, the characterization and definition of various cell types in a heterogeneous cell population, the evaluation of the purity of isolated subpopulations, and the measurement of cell size and volume are all common uses for flow cytometry. It enables the simultaneous examination of multiple parameters for a single cell. A flow cytometer uses lasers to produce light, which is subsequently dispersed by the sample's cells, recorded by detectors, and converted into signals for analysis and measurement.
The increasing innovations and technologies, and rising number of players in the market, and novel product launches are also propelling the growth of the Asia-Pacific flow cytometry market.
Asia-Pacific Flow Cytometry Market Dynamics
Drivers
-
Rising prevalence of chronic diseases
These increasing prevalence and incidences of chronic diseases are likely to drive market growth by focusing on cytometry devices. The increasing incidences of diseases lead to an increase in the Asia-Pacific market as many companies are investing in research and development. This resulted in the enormous lead in demand for advancements to diagnose the disease through quick and accurate techniques.
For instance,
-
In April 2019, Cytex Biosciences received clearance in FDA China for the approval of Dxp Athene, a new cytometer that is designed for diagnosis purposes in hospitals, laboratories, and clinics
Therefore, this is raising the demand for the Asia-Pacific flow cytometry market.
-
Increasing application of cytometry instruments
Technological developments in cytometry instruments are rising by combining several new techniques to provide high resolution and sensitivity to quantify new entities of cells.
The immunophenotypic analysis is important not only for the initial diagnosis and categorization of acute leukemia, chronic lymphoproliferative disorders, and malignant lymphomas but also for their treatment. Flow cytometry can be used as a sensitive assay to track patients' improvement after chemotherapy or transplantation and detect minimal residual illness (MRD).
For instance,
-
In June 2021, Cytek Biosciences launched a new dimensional sorter with wide resolution and fluorescence to produce an effortless sorting experience with advanced platforms involved in it
Thus, this is expected to act as a driver for the growth of the Asia-Pacific flow cytometry market.
Opportunities
-
Increase in adoption of flow cytometry techniques in research and academia
Flow cytometry is a sophisticated technique for measuring individual cells and other particles in suspension at a rate of thousands of cells per second. Flow cytometry has been extended to environmental investigations, extracellular vesicle analysis, and the capacity to use upwards of 30 different parameters for more extensive analysis. It is most typically used in the setting of immunology.
For instance,
-
In December 2018, the News-Medical.net article stated that combining fluorescent-tagged monoclonal antibodies with flow cytometry is commonly used among cancer researchers. Similarly, after over a decade of extensive research, high-throughput image-based flow cytometry is now accepted and widely used in scientific research and academics, particularly in cancer biology
Rising healthcare expenditure
The expense of money used by a country on its healthcare and its growth rate over time is inclined by a wide variety of economic and social factors, including the financing arrangements and structure of the organization of the health system. In particular, there is a strong association between the complete income level of a country and how much the population of that country spends on health care.
Also, the strategic initiatives taken by key market players will provide structural integrity and future opportunities for the Asia-Pacific flow cytometry market in the forecast period of 2023-2030.
Restraints/Challenges
- High cost of flow cytometry instruments
Flow cytometers come in a variety of shapes and sizes, although benchtop instruments are the most common. They offer optimal data analysis, the convenience of use, and upgrades and options for various systems, all of which are intended to solve customized separations, cell/particle sorting, exploratory cell analysis, and other issues. All flow cytometers feature three common components – fluids, optics, and electronics/informatics.
Flow cytometers are very expensive especially considering the cost associated with repair and maintenance.
COVID-19 Impact on the Asia-Pacific Flow Cytometry Market
COVID-19 has positively affected the market due to disease diagnosis and research purposes, which raises the demand for flow cytometry during this period.
Recent Development
- In January 2022, Sony Biotechnology, Inc. presented a novel closed cell isolation system CGX10 for use in GMP-compliant cell sorting applications. With the initiative, new growth opportunities were hoped for the company. Such advances in technology will lead to cost-effectiveness, greater accuracy and portability and are likely to create future growth opportunities.
Asia-Pacific Flow Cytometry Market Scope
Asia-Pacific flow cytometry market is segmented into product, technology, application, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.
Product
- Reagents and consumables
- Flow cytometry instruments
- Accessories
- Services
- Software
On the basis of product, the Asia-Pacific flow cytometry market is segmented into flow cytometry instruments, reagents and consumables, software, accessories, and services.
Technology
- Cell-based flow cytometry
- Bead-based flow cytometry
On the basis of technology, the Asia-Pacific flow cytometry market is segmented into cell-based flow cytometry and bead-based flow cytometry.
Application
- Research applications
- Clinical applications
- Industrial applications
On the basis of application, the Asia-Pacific flow cytometry market is segmented into research applications, clinical applications, and industrial applications.
End User
- Pharmaceuticals & biotechnology companies
- Academic & Research institutes
- Hospitals
- Clinical testing laboratories
- Blood bank
- Others
On the basis of end users, the Asia-Pacific flow cytometry market is segmented into academic & research institutes, hospitals, pharmaceutical & biotechnology companies, clinical testing laboratories, blood bank, and others.
Distribution Channel
- Retail sales
- Direct tenders
On the basis of the distribution channel, the Asia-Pacific flow cytometry market is segmented into retail sales and direct tenders.
Asia-Pacific Flow Cytometry Market Regional Analysis/Insights
O mercado de citometria de fluxo da Ásia-Pacífico é analisado, e os insights e tendências do tamanho do mercado são fornecidos por país, produto, tecnologia, aplicação, utilizador final e canal de distribuição, como mencionado acima.
Espera-se que o Japão domine o mercado de citometria de fluxo da Ásia-Pacífico devido às crescentes atividades de investigação e desenvolvimento para o diagnóstico e prevenção de doenças neste país. Estão a dominar o mercado da citometria de fluxo em termos de quota de mercado e receitas de mercado e continuarão a florescer o seu domínio durante o período de previsão.
A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações nas regulamentações do mercado que impactam as tendências atuais e futuras do mercado. Pontos de dados, como vendas de novos e de reposição, demografia do país, epidemiologia de doenças e tarifas de importação e exportação, são alguns dos principais indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas da Ásia-Pacífico e os desafios enfrentados devido à elevada concorrência de marcas locais e nacionais, e o impacto dos canais de vendas, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.
Análise do panorama competitivo e da quota de mercado da citometria de fluxo da Ásia-Pacífico
O panorama competitivo do mercado de citometria de fluxo da Ásia-Pacífico fornece detalhes sobre os concorrentes. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença na Ásia-Pacífico, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa, lançamento de produtos, largura e amplitude do produto e domínio da aplicação. Os dados fornecidos acima estão apenas relacionados com o foco da empresa no mercado de citometria de fluxo da Ásia-Pacífico.
Alguns dos principais players que operam no mercado de citometria de fluxo Ásia-Pacífico são a Thermo Fisher Scientific Inc., a BD, a Agilent Technologies, Inc., a Bio-Rad Laboratories, Inc., a Sysmex Corporation, a Coherent Corp., a Beckman Coulter, Inc. Uma subsidiária da Danaher Corporation), Cytek Biosciences, bioMérieux SA, Q2 Solutions (uma subsidiária da IQVIA), Cytonome/ST, LLC, Merck KGaA, Sony Biotechnology Inc., Cell Signaling Technology, Inc., Enzo Biochem Inc., Takara Bio Inc., CellKraft Biotech Unip. Ltd., IKEDA SCIENTIFIC Co., Ltd., Apogee Flow Systems Ltd., Sartorius AG, Bay bioscience Co., Ltd., Elabscience Biotechnology Inc., Miltenyi Biotec, CytoBuoy bv, ORFLO Technologies, BioLegend, Inc., NeoGenomics Laboratories, Nexcelom Bioscience LLC, entre outros.
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA PACIFIC FLOW CYTOMETRY MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT SEGMENT LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 RISING PREVALENCE OF CHRONIC DISEASES
5.1.2 INCREASING APPLICATION OF CYTOMETRY INSTRUMENTS
5.1.3 INCREASE IN USE OF FLOW CYTOMETRY IN DRUG DISCOVERY
5.1.4 GROWTH IN STEM CELL RESEARCH AND ACQUISITION OF RECOMBINATION OF DNA TECHNOLOGIES
5.2 RESTRAINTS
5.2.1 HIGH COST OF FLOW CYTOMETRY INSTRUMENTS
5.2.2 LIMITATIONS OF FLOW CYTOMETRY
5.2.3 LACK OF SKILLED PROFESSIONALS
5.3 OPPORTUNITIES
5.3.1 INCREASE IN ADOPTION OF FLOW CYTOMETRY TECHNIQUES IN RESEARCH AND ACADEMIA
5.3.2 DEVELOPMENT IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES
5.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS
5.3.4 DEVELOPING A PIPELINE OF STEM CELL RESEARCH
5.4 CHALLENGES
5.4.1 DIFFICULTY IN THE DEVELOPMENT AND VALIDATION OF FLOW CYTOMETRY ASSAYS
5.4.2 COMPLEXITIES RELATED TO REAGENT DEVELOPMENT
6 ASIA PACIFIC FLOW CYTOMETRY MARKET, BY PRODUCT
6.1 OVERVIEW
6.2 REAGENTS AND CONSUMABLES
6.2.1 DYE
6.2.2 ANTIBODIES
6.2.3 BEADS
6.2.4 OTHERS
6.3 FLOW CYTOMETRY INSTRUMENTS
6.3.1 CELL ANALYZERS
6.3.1.1 CELL ANALYZERS, BY TYPE
6.3.1.1.1 IMAGING FLOW CYTOMETERS
6.3.1.1.2 NON-IMAGING FLOW CYTOMETERS
6.3.1.2 CELL ANALYZERS, BY MODALITY
6.3.1.2.1 BENCHTOP
6.3.1.2.2 STANDALONE
6.3.2 CELL SORTERS
6.3.2.1 BENCHTOP
6.3.2.2 STANDALONE
6.4 ACCESSORIES
6.4.1 FILTERS
6.4.2 DETECTORS
6.4.3 OTHERS
6.5 SERVICES
6.6 SOFTWARE
7 ASIA PACIFIC FLOW CYTOMETRY MARKET, BY TECHNOLOGY
7.1 OVERVIEW
7.2 CELL-BASED FLOW CYTOMETRY
7.3 BEAD-BASED FLOW CYTOMETRY
8 ASIA PACIFIC FLOW CYTOMETRY MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 RESEARCH APPLICATIONS
8.2.1 CELL CYCLE ANALYSIS
8.2.2 CELL SORTING/SCREENING
8.2.3 CELL TRANSFECTION/VIABILITY
8.2.4 PHARMACEUTICAL AND BIOTECHNOLOGY
8.2.4.1 DRUG DISCOVERY
8.2.4.2 STEM CELL RESEARCH
8.2.4.3 IN VITRO TOXICITY TESTING
8.2.5 IMMUNOLOGY
8.2.6 APOPTOSIS
8.2.7 CELL COUNTING
8.2.8 OTHERS
8.3 CLINICAL APPLICATIONS
8.3.1 HAEMATOLOGY
8.3.2 CANCER
8.3.3 IMMUNODEFICIENCY DISEASES
8.3.4 ORGAN TRANSPLANTATION
8.3.5 OTHER CLINICAL APPLICATION
8.4 INDUSTRIAL APPLICATIONS
9 ASIA PACIFIC FLOW CYTOMETRY MARKET, BY END USER
9.1 OVERVIEW
9.2 PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES
9.3 ACADEMIC & RESEARCH INSTITUTES
9.4 HOSPITALS
9.5 CLINICAL TESTING LABORATORIES
9.6 BLOOD BANK
9.7 OTHERS
10 ASIA PACIFIC FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 RETAIL SALES
10.3 DIRECT TENDERS
11 ASIA PACIFIC FLOW CYTOMETRY MARKET, BY GEOGRAPHY
11.1 ASIA-PACIFIC
11.1.1 JAPAN
11.1.2 CHINA
11.1.3 INDIA
11.1.4 SOUTH KOREA
11.1.5 AUSTRALIA
11.1.6 SINGAPORE
11.1.7 THAILAND
11.1.8 MALAYSIA
11.1.9 INDONESIA
11.1.10 PHILIPPINES
11.1.11 REST OF ASIA-PACIFIC
12 ASIA PACIFIC FLOW CYTOMETRY MARKET, COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
13 SWOT ANALYSIS
14 COMPANY PROFILE
14.1 THERMO FISHER SCIENTIFIC INC.
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 BD
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENT
14.2.5.1 COLLABORATION
14.3 AGILENT TECHNOLOGIES, INC.
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 SARTORIUS AG
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENT
14.5 NEXCELOM BIOSCIENCE LLC
14.5.1 COMPANY SNAPSHOT
14.5.2 PRODUCT PORTFOLIO
14.5.3 RECENT DEVELOPMENT
14.5.4 COMPANY SHARE ANALYSIS
14.6 APOGEE FLOW SYSTEMS LTD.
14.6.1 COMPANY SNAPSHOT
14.6.2 PRODUCT PORTFOLIO
14.6.3 RECENT DEVELOPMENT
14.7 BAY BIOSCIENCE CO., LTD.
14.7.1 COMPANY SNAPSHOT
14.7.2 PRODUCT PORTFOLIO
14.7.3 RECENT DEVELOPMENT
14.8 BIOMÉRIEUX
14.8.1 COMPANY SNAPSHOT
14.8.2 REVENUE ANALYSIS
14.8.3 PRODUCT PORTFOLIO
14.8.4 RECENT DEVELOPMENT
14.9 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER CORPORATION)
14.9.1 COMPANY SNAPSHOT
14.9.2 REVENUE ANALYSIS
14.9.3 PRODUCT PORTFOLIO
14.9.4 RECENT DEVELOPMENTS
14.9.4.1 ACQUISITION
14.9.4.2 PRODUCT LAUNCH
14.1 BENNUBIO INC.
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENT
14.11 BIOLEGEND, INC.
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENT
14.12 BIO-RAD LABORATORIES, INC.
14.12.1 COMPANY SNAPSHOT
14.12.2 REVENUE ANALYSIS
14.12.3 PRODUCT PORTFOLIO
14.12.4 RECENT DEVELOPMENT
14.13 CELL SIGNALING TECHNOLOGY, INC.
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENT
14.14 CELLKRAFT BIOTECH PVT. LTD
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENT
14.15 CYTEK BIOSCIENCES
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENTS
14.15.3.1 PRODUCT LAUNCH
14.15.3.2 ACQUISITION
14.16 CYTOBUOY B.V.
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENT
14.17 CYTONOME/ST, LLC
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.18 COHERENT CORP.
14.18.1 COMPANY SNAPSHOT
14.18.2 REVENUE ANALYSIS
14.18.3 PRODUCT PORTFOLIO
14.18.4 RECENT DEVELOPMENTS
14.18.4.1 Announcement
14.18.4.2 PRODUCT LAUNCH
14.18.4.3 AWARDS
14.18.5 RECENT DEVELOPMENT
14.19 ELABSCIENCE BIOTECHNOLOGY INC.
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENT
14.2 ENZO BIOCHEM INC.
14.20.1 COMPANY SNAPSHOT
14.20.2 REVENUE ANALYSIS
14.20.3 PRODUCT PORTFOLIO
14.20.4 RECENT DEVELOPMENT
14.21 IKEDA SCIENTIFIC CO., LTD.
14.21.1 COMPANY SNAPSHOT
14.21.2 PRODUCT PORTFOLIO
14.21.3 RECENT DEVELOPMENT
14.22 MERCK KGAA
14.22.1 COMPANY SNAPSHOT
14.22.2 REVENUE ANALYSIS
14.22.3 PRODUCT PORTFOLIO
14.22.4 RECENT DEVELOPMENT
14.23 MILTENYI BIOTEC
14.23.1 COMPANY SNAPSHOT
14.23.2 PRODUCT PORTFOLIO
14.23.3 RECENT DEVELOPMENT
14.23.3.1 PRODUCT LAUNCH
14.24 NANOCELLECT BIOMEDICAL
14.24.1 COMPANY SNAPSHOT
14.24.2 PRODUCT PORTFOLIO
14.24.3 RECENT DEVELOPMENTS
14.25 NEOGENOMICS LABORATORIES
14.25.1 COMPANY SNAPSHOT
14.25.2 REVENUE ANALYSIS
14.25.3 PRODUCT PORTFOLIO
14.25.4 RECENT DEVELOPMENT
14.26 ON-CHIP BIOTECHNOLOGIES CO., LTD. CORPORATION
14.26.1 COMPANY SNAPSHOT
14.26.2 PRODUCT PORTFOLIO
14.26.3 RECENT DEVELOPMENTS
14.27 ORFLO TECHNOLOGIES
14.27.1 COMPANY SNAPSHOT
14.27.2 PRODUCT PORTFOLIO
14.27.3 RECENT DEVELOPMENT
14.28 Q2 SOLUTION
14.28.1 COMPANY SNAPSHOT
14.28.2 REVENUE ANALYSIS
14.28.3 SERVICE PORTFOLIO
14.28.4 RECENT DEVELOPMENT
14.29 SONY BIOTECHNOLOGY INC.
14.29.1 COMPANY SNAPSHOT
14.29.2 PRODUCT PORTFOLIO
14.29.3 RECENT DEVELOPMENT
14.3 STRATEDIGM, INC
14.30.1 COMPANY SNAPSHOT
14.30.2 PRODUCT PORTFOLIO
14.30.3 RECENT DEVELOPMENT
14.31 SYSMEX CORPORATION
14.31.1 COMPANY SNAPSHOT
14.31.2 REVENUE ANALYSIS
14.31.3 PRODUCT PORTFOLIO
14.31.4 RECENT DEVELOPMENT
14.32 TAKARA BIO INC.
14.32.1 COMPANY SNAPSHOT
14.32.2 REVENUE ANALYSIS
14.32.3 PRODUCT PORTFOLIO
14.32.4 RECENT DEVELOPMENTS
14.33 UNION BIOMETRICA, INC.
14.33.1 COMPANY SNAPSHOT
14.33.2 PRODUCT PORTFOLIO
14.33.3 RECENT DEVELOPMENT
15 QUESTIONNAIRE
16 RELATED REPORTS
Lista de Tabela
TABLE 1 ASIA PACIFIC FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 2 ASIA PACIFIC REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 ASIA PACIFIC REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 4 ASIA PACIFIC FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 5 ASIA PACIFIC FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 6 ASIA PACIFIC CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 7 ASIA PACIFIC CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 8 ASIA PACIFIC CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 9 ASIA PACIFIC ACCESSORIES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 10 ASIA PACIFIC ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 11 ASIA PACIFIC SERVICES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 12 ASIA PACIFIC SOFTWARE IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 13 ASIA PACIFIC FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 14 ASIA PACIFIC CELL-BASED FLOW CYTOMETRY IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 ASIA PACIFIC BEAD-BASED FLOW CYTOMETRY IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 16 ASIA PACIFIC FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 17 ASIA PACIFIC RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 18 ASIA PACIFIC RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 19 ASIA PACIFIC PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 20 ASIA PACIFIC CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 ASIA PACIFIC CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 22 ASIA PACIFIC INDUSTRIAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 ASIA PACIFIC FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 24 ASIA PACIFIC PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 25 ASIA PACIFIC ACADEMIC & RESEARCH INSTITUTES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 26 ASIA PACIFIC HOSPITALS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 27 ASIA PACIFIC CLINICAL TESTING LABORATORIES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 28 ASIA PACIFIC BLOOD BANK IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 ASIA PACIFIC OTHERS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 30 ASIA PACIFIC FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 31 ASIA PACIFIC RETAIL SALES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 32 ASIA PACIFIC DIRECT TENDERS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 33 ASIA-PACIFIC FLOW CYTOMETRY MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 34 ASIA-PACIFIC FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 35 ASIA-PACIFIC REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 36 ASIA-PACIFIC FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 37 ASIA-PACIFIC CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 38 ASIA-PACIFIC CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 39 ASIA-PACIFIC CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 40 ASIA-PACIFIC ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 41 ASIA-PACIFIC FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 42 ASIA-PACIFIC FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 43 ASIA-PACIFIC RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 44 ASIA-PACIFIC PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 45 ASIA-PACIFIC CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 46 ASIA-PACIFIC FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 47 ASIA-PACIFIC FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 48 JAPAN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 49 JAPAN REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 50 JAPAN FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 51 JAPAN CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 52 JAPAN CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 53 JAPAN CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 54 JAPAN ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 55 JAPAN FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 56 JAPAN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 57 JAPAN RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 58 JAPAN PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 59 JAPAN CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 60 JAPAN FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 61 JAPAN FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 62 CHINA FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 63 CHINA REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 64 CHINA FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 65 CHINA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 66 CHINA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 67 CHINA CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 68 CHINA ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 69 CHINA FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 70 CHINA FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 71 CHINA RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 72 CHINA PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 73 CHINA CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 74 CHINA FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 75 CHINA FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 76 INDIA FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 77 INDIA REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 78 INDIA FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 79 INDIA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 80 INDIA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 81 INDIA CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 82 INDIA ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 83 INDIA FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 84 INDIA FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 85 INDIA RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 86 INDIA PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 87 INDIA CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 88 INDIA FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 89 INDIA FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 90 SOUTH KOREA FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 91 SOUTH KOREA REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 92 SOUTH KOREA FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 93 SOUTH KOREA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 94 SOUTH KOREA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 95 SOUTH KOREA CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 96 SOUTH KOREA ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 97 SOUTH KOREA FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 98 SOUTH KOREA FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 99 SOUTH KOREA RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 100 SOUTH KOREA PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 101 SOUTH KOREA CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 102 SOUTH KOREA FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 103 SOUTH KOREA FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 104 AUSTRALIA FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 105 AUSTRALIA REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 106 AUSTRALIA FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 107 AUSTRALIA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 108 AUSTRALIA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 109 AUSTRALIA CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 110 AUSTRALIA ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 111 AUSTRALIA FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 112 AUSTRALIA FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 113 AUSTRALIA RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 114 AUSTRALIA PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 115 AUSTRALIA CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 116 AUSTRALIA FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 117 AUSTRALIA FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 118 SINGAPORE FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 119 SINGAPORE REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 120 SINGAPORE FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 121 SINGAPORE CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 122 SINGAPORE CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 123 SINGAPORE CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 124 SINGAPORE ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 125 SINGAPORE FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 126 SINGAPORE FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 127 SINGAPORE RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 128 SINGAPORE PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 129 SINGAPORE CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 130 SINGAPORE FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 131 SINGAPORE FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 132 THAILAND FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 133 THAILAND REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 134 THAILAND FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 135 THAILAND CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 136 THAILAND CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 137 THAILAND CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 138 THAILAND ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 139 THAILAND FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 140 THAILAND FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 141 THAILAND RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 142 THAILAND PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 143 THAILAND CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 144 THAILAND FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 145 THAILAND FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 146 MALAYSIA FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 147 MALAYSIA REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 148 MALAYSIA FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 149 MALAYSIA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 150 MALAYSIA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 151 MALAYSIA CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 152 MALAYSIA ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 153 MALAYSIA FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 154 MALAYSIA FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 155 MALAYSIA RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 156 MALAYSIA PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 157 MALAYSIA CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 158 MALAYSIA FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 159 MALAYSIA FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 160 INDONESIA FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 161 INDONESIA REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 162 INDONESIA FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 163 INDONESIA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 164 INDONESIA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 165 INDONESIA CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 166 INDONESIA ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 167 INDONESIA FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 168 INDONESIA FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 169 INDONESIA RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 170 INDONESIA PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 171 INDONESIA CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 172 INDONESIA FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 173 INDONESIA FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 174 PHILIPPINES FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 175 PHILIPPINES REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 176 PHILIPPINES FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 177 PHILIPPINES CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 178 PHILIPPINES CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 179 PHILIPPINES CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 180 PHILIPPINES ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 181 PHILIPPINES FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 182 PHILIPPINES FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 183 PHILIPPINES RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 184 PHILIPPINES PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 185 PHILIPPINES CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 186 PHILIPPINES FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 187 PHILIPPINES FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 188 REST OF ASIA-PACIFIC FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
Lista de Figura
FIGURE 1 ASIA PACIFIC FLOW CYTOMETRY MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC FLOW CYTOMETRY MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC FLOW CYTOMETRY MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC FLOW CYTOMETRY MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC FLOW CYTOMETRY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC FLOW CYTOMETRY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC FLOW CYTOMETRY MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA PACIFIC FLOW CYTOMETRY MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 ASIA PACIFIC FLOW CYTOMETRY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA PACIFIC FLOW CYTOMETRY MARKET: SEGMENTATION
FIGURE 11 INCREASING INCIDENCE AND PREVALENCE OF CHRONIC DISEASES ARE EXPECTED TO DRIVE THE ASIA PACIFIC FLOW CYTOMETRY MARKET IN THE FORECAST PERIOD
FIGURE 12 THE REAGENTS AND CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC FLOW CYTOMETRY MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC FLOW CYTOMETRY MARKET
FIGURE 14 ASIA PACIFIC FLOW CYTOMETRY MARKET: BY PRODUCT, 2022
FIGURE 15 ASIA PACIFIC FLOW CYTOMETRY MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 16 ASIA PACIFIC FLOW CYTOMETRY MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 17 ASIA PACIFIC FLOW CYTOMETRY MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 18 ASIA PACIFIC FLOW CYTOMETRY MARKET: BY TECHNOLOGY, 2022
FIGURE 19 ASIA PACIFIC FLOW CYTOMETRY MARKET: BY TECHNOLOGY, 2023-2030 (USD MILLION)
FIGURE 20 ASIA PACIFIC FLOW CYTOMETRY MARKET: BY TECHNOLOGY, CAGR (2023-2030)
FIGURE 21 ASIA PACIFIC FLOW CYTOMETRY MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 22 ASIA PACIFIC FLOW CYTOMETRY MARKET: BY APPLICATION, 2022
FIGURE 23 ASIA PACIFIC FLOW CYTOMETRY MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 24 ASIA PACIFIC FLOW CYTOMETRY MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 25 ASIA PACIFIC FLOW CYTOMETRY MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 ASIA PACIFIC FLOW CYTOMETRY MARKET: BY END USER, 2022
FIGURE 27 ASIA PACIFIC FLOW CYTOMETRY MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 28 ASIA PACIFIC FLOW CYTOMETRY MARKET: BY END USER, CAGR (2023-2030)
FIGURE 29 ASIA PACIFIC FLOW CYTOMETRY MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 ASIA PACIFIC FLOW CYTOMETRY MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 ASIA PACIFIC FLOW CYTOMETRY MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 32 ASIA PACIFIC FLOW CYTOMETRY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 ASIA PACIFIC FLOW CYTOMETRY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 ASIA-PACIFIC FLOW CYTOMETRY MARKET: SNAPSHOT (2022)
FIGURE 35 ASIA-PACIFIC FLOW CYTOMETRY MARKET: BY COUNTRY (2022)
FIGURE 36 ASIA-PACIFIC FLOW CYTOMETRY MARKET: BY COUNTRY (2023 & 2030)
FIGURE 37 ASIA-PACIFIC FLOW CYTOMETRY MARKET: BY COUNTRY (2022 & 2030)
FIGURE 38 ASIA-PACIFIC FLOW CYTOMETRY MARKET: PRODUCT (2023-2030)
FIGURE 39 ASIA PACIFIC FLOW CYTOMETRY MARKET: COMPANY SHARE 2022 (%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
